Respiratory Disease Vaccine Market Projected to Exceed USD 113.7 Bn by 2032 Driven by 2% CAGR | Research by Marketresearch.biz
Marketresearch.biz reports that the The Respiratory Disease Vaccine Market size is predicted to reach approximately USD 113.7 Bn by 2032, from a valuation of USD 93.5 Bn in 2022, growing at a CAGR of 2.0% during the forecast period from 2023 to 2032. Overview of the Respiratory Disease Vaccine Market The respiratory disease vaccine market addresses prevention against various respiratory infections like influenza, pneumonia, and COVID-19. Market growth is fueled by factors such as increasing awareness of vaccination, government initiatives for immunization programs, and the ongoing COVID-19 pandemic. However, challenges like vaccine hesitancy and supply chain disruptions impact market dynamics.…
- Date: May 16, 2024
- Author: Timmy Thomas
- Category: PharmiWeb